Braveheart Bio, Inc. (BRVE)
NASDAQ: BRVE · Real-Time Price · USD
26.95
+0.67 (2.55%)
Sep 2, 2026, 4:00 PM EDT - Market closed
Braveheart Bio Market Cap
Braveheart Bio has a market cap or net worth of $1.73 billion as of September 2, 2026.
Market Cap
1.73B
Enterprise Value
1.65B
1-Year Change
n/a
Ranking
Category
Stock Price
$26.95
ChartMarket Cap Chart
Since the IPO on August 6, 2026, Braveheart Bio's market cap has increased from $1.27B to $1.73B, an increase of 35.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.73B | 2.55% |
| Sep 1, 2026 | 1.69B | 3.06% |
| Aug 31, 2026 | 1.64B | -7.07% |
| Aug 28, 2026 | 1.76B | -1.51% |
| Aug 27, 2026 | 1.79B | 0.36% |
| Aug 26, 2026 | 1.78B | 0.43% |
| Aug 25, 2026 | 1.77B | 0.51% |
| Aug 24, 2026 | 1.76B | -0.29% |
| Aug 21, 2026 | 1.77B | 0.58% |
| Aug 20, 2026 | 1.76B | -5.35% |
| Aug 19, 2026 | 1.86B | 8.30% |
| Aug 18, 2026 | 1.72B | -3.29% |
| Aug 17, 2026 | 1.77B | 2.33% |
| Aug 14, 2026 | 1.73B | 4.08% |
| Aug 13, 2026 | 1.67B | -0.69% |
| Aug 12, 2026 | 1.68B | 4.56% |
| Aug 11, 2026 | 1.60B | -9.15% |
| Aug 10, 2026 | 1.77B | -8.23% |
| Aug 7, 2026 | 1.93B | 51.37% |
| Aug 6, 2026 | 1.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.73B |
| Syndax Pharmaceuticals | 1.72B |
| Damora Therapeutics | 1.69B |
| AnaptysBio | 1.67B |
| Ascentage Pharma Group International | 1.57B |
| Novavax | 1.56B |
| SL Science Holding | 1.55B |
| Avalyn Pharma | 1.55B |